After Natco, Bajaj Healthcare files compulsory license against Eli Lilly; EPO Enlarged Board of Appeal issues decision on ‘double patenting’ and more

Bajaj Healthcare has applied for a compulsory license against Eli Lilly for Baricitinib, citing affordability concerns. The post also covers the EPO’s decision on double patenting, updates from the IP5 meeting on AI patents, and new initiatives by WHO, WTO, and WIPO.

Read more about After Natco, Bajaj Healthcare files compulsory license against Eli Lilly; EPO Enlarged Board of Appeal issues decision on ‘double patenting’ and more

Free Session on Patent Licensing and Commercialization by BananaIP and K-Tech CoE Data Science & AI – NASSCOM

The concluding session of the Intellectual Property MasterClass will address patent licensing and commercialization, with a focus on practical and legal aspects for businesses. Led by experienced professionals, this free session provides valuable insights for startups, SMEs, and innovators.

Read more about Free Session on Patent Licensing and Commercialization by BananaIP and K-Tech CoE Data Science & AI – NASSCOM

Free Masterclass on IP; Nokia and Daimler settle SEP patent dispute; EU submits alternative proposal to WTO against IP waiver and more

This week’s patent news features a free masterclass on patent filing, Nokia and Daimler’s settlement of a SEP dispute, and the EU’s alternative proposal to the WTO on IP waivers. Also covered are updates on the USPTO’s move to structured text filing for patent applications.

Read more about Free Masterclass on IP; Nokia and Daimler settle SEP patent dispute; EU submits alternative proposal to WTO against IP waiver and more